Pfizer, Novartis May Join Amgen in Bidding for Onyx: Sources

Published July 5, 2013

Pfizer, Novartis may join Amgen in bidding for Onyx: sources

Filed under: Chicago Drug Treatment

Onyx sells Nexavar, a treatment for liver and kidney cancer, and the new colon cancer drug Stivarga – both in partnership with Germany's Bayer. Onyx last year began selling Krypolis, which some analysts estimate will reach peak annual sales of $ 3 billion.
Read more on Chicago Tribune

US stocks turn lower after Egypt turmoil worsens

Filed under: Chicago Drug Treatment

Achillion Pharmaceuticals fell $ 2.10, or 25.1 percent, to $ 6.26 after the drug developer said regulators Monday placed a hold on an early-stage study involving its potential hepatitis C treatment. — DaVita HealthCare Partners fell $ 7.15, or 5.9 …
Read more on Aurora Beacon News

Onyx explores possible sale after rejecting Amgen offer

Filed under: Chicago Drug Treatment

Onyx sells Nexavar, a treatment for liver and kidney cancer, as well as colon cancer drug Stivarga in partnership with German pharmaceutical company Bayer AG . Last year, Onyx launched sales of blood cancer drug Krypolis, which Karnauskas estimates …
Read more on Chicago Tribune